{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:58:41Z","timestamp":1780970321955,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"name":"VinGroup Innovation Foundation-VINIF","award":["VINIF.2020.DA.06"],"award-info":[{"award-number":["VINIF.2020.DA.06"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32CA186873"],"award-info":[{"award-number":["T32CA186873"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45659-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:28:44Z","timestamp":1776407324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese population"],"prefix":"10.1038","volume":"16","author":[{"given":"Anh Gia","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Vu-Khanh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Thi-Hai","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanh Sy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Lan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia Chinh","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thau Manh","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan Thanh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Tuan","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Thi","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Duy","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Thi-Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Thi","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang Binh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung N.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"45659_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"45659_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"45659_CR3","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ijc.31280","volume":"142","author":"D Maucort-Boulch","year":"2018","unstructured":"Maucort-Boulch, D., de Martel, C., Franceschi, S. & Plummer, M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int. J. Cancer. 142, 2471\u20132477 (2018).","journal-title":"Int. J. Cancer"},{"key":"45659_CR4","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"45659_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico, G., Garcia-Tsao, G. & Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol. 44, 217\u2013231 (2006).","journal-title":"J. Hepatol."},{"key":"45659_CR6","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"45659_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li, J. et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 4, 389\u2013398 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"45659_CR8","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31, S32\u201350 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"45659_CR9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","volume":"10","author":"DL White","year":"2012","unstructured":"White, D. L., Kanwal, F. & El-Serag, H. B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin. Gastroenterol. Hepatol. 10, 1342\u20131359e2 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"45659_CR10","doi-asserted-by":"crossref","unstructured":"Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: Current concepts and future challenges. Nat Rev. Gastroenterol. Hepatol.  (2019).","DOI":"10.1038\/s41575-019-0145-7"},{"key":"45659_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330\u2013344 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"45659_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"45659_CR13","unstructured":"Baveno, V. I. I. Renewing consensus in portal hypertension. https:\/\/pubmed.ncbi.nlm.nih.gov\/35120736\/"},{"key":"45659_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C-T Wai","year":"2003","unstructured":"Wai, C-T. et al. Lok AS-F. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"},{"key":"45659_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"45659_CR16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846\u2013854 (2007).","journal-title":"Hepatology"},{"key":"45659_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S. & Neuschwander-Tetri, B. A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57, 1441\u20131447 (2008).","journal-title":"Gut"},{"key":"45659_CR18","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao, G. et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 66, 1486\u20131501 (2017).","journal-title":"Hepatology"},{"key":"45659_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal, A. J. et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores. J. Hepatol. 78, 247\u2013259 (2023).","journal-title":"J. Hepatol."},{"key":"45659_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jama.2024.1447","volume":"331","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease. JAMA 331, 1287\u20131297 (2024).","journal-title":"JAMA"},{"key":"45659_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/abr.abr_114_19","volume":"8","author":"L Kamali","year":"2019","unstructured":"Kamali, L., Adibi, A., Ebrahimian, S., Jafari, F. & Sharifi, M. Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty Liver. Adv. Biomed. Res. 8, 69 (2019).","journal-title":"Adv. Biomed. Res."},{"key":"45659_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/oxfordjournals.aje.a009876","volume":"149","author":"M Garc\u00eda-Closas","year":"1999","unstructured":"Garc\u00eda-Closas, M. & Lubin, J. H. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am. J. Epidemiol. 149, 689\u2013692 (1999).","journal-title":"Am. J. Epidemiol."},{"key":"45659_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.20506","volume":"41","author":"M Ziol","year":"2005","unstructured":"Ziol, M. et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41, 48\u201354 (2005).","journal-title":"Hepatology"},{"key":"45659_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 1104\u20131112 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"45659_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"12","author":"Y Sumida","year":"2012","unstructured":"Sumida, Y. et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 12, 2 (2012).","journal-title":"BMC Gastroenterol."},{"key":"45659_CR26","first-page":"159","volume":"10","author":"TK Tran","year":"2018","unstructured":"Tran, T. K. & Nguyen, D. M. The role of non-invasive methods in evaluating liver fibrosis of patients with no-alcoholic steatohepatitis. Imaging Med. 10, 159\u2013163 (2018).","journal-title":"Imaging Med."},{"key":"45659_CR27","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2006.03.005","volume":"44","author":"A Lonardo","year":"2006","unstructured":"Lonardo, A., Carani, C., Carulli, N. & Loria, P. Endocrine NAFLD a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J. Hepatol. 44, 1196\u20131207 (2006).","journal-title":"J. Hepatol."},{"key":"45659_CR28","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","volume":"20","author":"M Bertolotti","year":"2014","unstructured":"Bertolotti, M. et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J. Gastroenterol. 20, 14185\u201314204 (2014).","journal-title":"World J. Gastroenterol."},{"key":"45659_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.clnu.2009.12.011","volume":"29","author":"S Meeuwsen","year":"2010","unstructured":"Meeuwsen, S., Horgan, G. W. & Elia, M. The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex. Clin. Nutr. 29, 560\u2013566 (2010).","journal-title":"Clin. Nutr."},{"key":"45659_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157\u2013163 (2004).","journal-title":"Lancet"},{"key":"45659_CR31","first-page":"370","volume":"17","author":"W-H Pan","year":"2008","unstructured":"Pan, W-H. & Yeh, W-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac. J. Clin. Nutr. 17, 370\u2013374 (2008).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"45659_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"45659_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep4.1519","volume":"4","author":"S Young","year":"2020","unstructured":"Young, S. et al. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis. Hepatol. Commun. 4, 953\u2013972 (2020).","journal-title":"Hepatol. Commun."},{"key":"45659_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","volume":"62","author":"VWS Wong","year":"2015","unstructured":"Wong, V. W. S. et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J. Hepatol. 62, 182\u2013189 (2015).","journal-title":"J. Hepatol."},{"key":"45659_CR35","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/hep.29041","volume":"65","author":"FV Bruschi","year":"2017","unstructured":"Bruschi, F. V. et al. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology 65, 1875\u20131890 (2017).","journal-title":"Hepatology"},{"key":"45659_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hep.31113","volume":"71","author":"S Stender","year":"2020","unstructured":"Stender, S. & Loomba, R. PNPLA3 Genotype and Risk of Liver and All-Cause Mortality. Hepatology 71, 777\u2013779 (2020).","journal-title":"Hepatology"},{"key":"45659_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2013.476","volume":"109","author":"AG Singal","year":"2014","unstructured":"Singal, A. G. et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am. J. Gastroenterol. 109, 325\u2013334 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"45659_CR38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41395-018-0041-8","volume":"113","author":"F Stickel","year":"2018","unstructured":"Stickel, F. et al. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Am. J. Gastroenterol. 113, 1475\u20131483 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"45659_CR39","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch, S. et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat. Genet. 47, 1443\u20131448 (2015).","journal-title":"Nat. Genet."},{"key":"45659_CR40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41366-023-01346-w","volume":"47","author":"A De","year":"2023","unstructured":"De, A. et al. Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD. Int. J. Obes. (Lond). 47, 986\u2013992 (2023).","journal-title":"Int. J. Obes. (Lond)"},{"key":"45659_CR41","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei, J. L. et al. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. Am. J. Gastroenterol. 110, 1306\u20131314 (2015). quiz 1315.","journal-title":"Am. J. Gastroenterol."},{"key":"45659_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.14401","volume":"47","author":"S Sookoian","year":"2018","unstructured":"Sookoian, S. & Pirola, C. J. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 47, 16\u201325 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"45659_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.clinre.2014.08.014","volume":"39","author":"SP Singh","year":"2015","unstructured":"Singh, S. P. et al. Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? Clin. Res. Hepatol. Gastroenterol. 39, 482\u2013488 (2015).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"45659_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1055\/s-0035-1559767","volume":"47","author":"B Wang","year":"2015","unstructured":"Wang, B. et al. Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis. Horm. Metab. Res. 47, 839\u2013845 (2015).","journal-title":"Horm. Metab. Res."},{"key":"45659_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"Kramer, C. K., Zinman, B. & Retnakaran, R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann. Intern. Med. 159, 758\u2013769 (2013).","journal-title":"Ann. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45659-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:02:55Z","timestamp":1780966975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45659-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45659-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8130849\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17802"}}